Does Guardant Health (GH) Have Long-Runway for Growth?
Baron Capital, an investment management company, released its Q1 2026 investor letter for the “Baron Health Care Fund”. A copy of the letter is available to download here.
Guardant Health Inc. (GH)
Market is closed
Sector: Services-Medical Laboratories
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 8,843,000 | $14,874,988 | +3902% | 0.1% | |
| 2. | 30,500 | $2,817,285 | -67% | 0.02% | |
| 3. | Leucadia National Ian Cumming And Joseph Steinberg | 18,879 | $1,743,853 | -71% | 0.01% |
| 4. | 1,533,000 | $1,565,973 | +125% | 0.01% | |
| 5. | 1,257,000 | $1,278,149 | 0.05% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $17.82 | 2,187 | $38,962.72 | 12,722 | 2024-03-18 | Filing | |
| $32.78 | 750 | $24,584.25 | 5,193 | 2023-06-09 | Filing | |
| $32.68 | 2,231 | $72,913.77 | 4,443 | 2023-06-09 | Filing | |
| $26.15 | 8,600 | $224,927.84 | 2,049,238 | 2023-03-15 | Filing | |
| $26.33 | 84,452 | $2,223,908.30 | 2,040,638 | 2023-03-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $84.83 | 116 | $9,840.28 | 8,528 | 2026-04-16 | Filing | |
| $92.68 | 3,832 | $355,149.76 | 20,990 | 2026-04-06 | Filing | |
| $88.09 | 348 | $30,655.32 | 8,394 | 2026-03-18 | Filing | |
| $87.04 | 3,000 | $261,111.00 | 43,601 | 2026-03-16 | Filing | |
| $91.30 | 300 | $27,390.03 | 1,193 | 2026-03-06 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 5,837,992 | $539,255,321 | 0.03% | |
| 2. | 5,624,180 | $519,505,507 | 0.01% | |
| 3. | 3,859,046 | $356,460,078 | 0.36% | |
| 4. | 1,405,837 | $129,857,164 | 0.02% | |
| 5. | 1,391,187 | $128,504,033 | 0.02% |
News See All
Guardant Health (GH) and Verana Health Announces New Partnership
Guardant Health, Inc. (NASDAQ:GH) is one of the best high growth healthcare stocks to buy now. Guardant Health, Inc.
11 High Growth Healthcare Stocks to Buy Now
On March 26, Stephanie Link, Hightower chief investment strategist, appeared on CNBC's ‘Squawk Box’ to talk about the latest market trends, where investors can find opportunities, and the effects ...
15 Most Promising Stocks Under $100 to Buy
On March 12, Roger Ferguson, former Fed Vice Chair, joined 'Closing Bell' on CNBC to discuss what to expect from the Federal Reserve next week.
Why Guardant Health’s (GH) 2026 Screening Story Reinforced Piper Sandler’s Bullish View
As of March 13, 2026, Guardant Health carried a Moderate Buy consensus from 23 analysts, based on 21 Buy ratings, one Hold, and one Sell.
11 Best Growth Stocks to Invest in According to Billionaires
Infotech and biotech remain two of the clearer growth pockets because the underlying spending data is still expanding.
Here’s Why Artisan Small Cap Fund Bets on Guardant Health (GH)
Artisan Partners, an investment management company, released its fourth-quarter 2025 investor letter for “Artisan Small Cap Fund”. A copy of the letter can be downloaded here.
Guardant Health, Inc. (GH) Strengthens Health Technology Portfolio with MetaSight Diagnostics Acquisition
Guardant Health Inc. (NASDAQ:GH) is one of the best cancer stocks to invest in now. On February 23, Guardant Health Inc.
11 Best Cancer Stocks to Invest In Now
Pharmaceutical companies are a blend of defensive income plays and growth opportunities.
Guardant Health (GH) Gained from Better-Than-Expected Results
Aristotle Funds, an investment advisor, released its “Growth Equity Fund” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. U.S.
Hedge Fund Resource Center